Drawing for TAIHO ONCOLOGY

USPTO serial 86235705

TAIHO ONCOLOGY

Reviewed by CopyMark Law Group

Reg. 4710794Status 800Registered
Filing date
Status date
Registration date
Mar 31, 2015
Examiner
DELANEY, ZHALEH SYBIL
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with TAIHO ONCOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen Lim

Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 West 42nd Street, 17th FloorNEW YORK, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, anti-cancer agents, anti-tumor agents, [ anti-ulcerogenic agents, agents for treatment of immunological diseases, agents for the treatment of urinary diseases, agents for pain, antiemetic agents, diagnostic agents, ] preparations and substances for medical purposes [ , preparations for detecting genetic predispositions for medical purposes ]ACTIVE—
042Scientific research for medical purposes in the field of cancer, tumors [, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ] ; testing, inspection, research or evaluation of pharmaceuticals; [ advisory, consultancy or information services relating to testing, inspection, research or evaluation of pharmaceuticals and medicines; ] providing medical and scientific research information about the results of clinical trials for pharmaceutical products [ ; design and development of computer hardware and software for use in the field of medicine; research and development of medical technology ]ACTIVE—
044Medical diagnostic testing in the fields of cancer, tumors [ , ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ] ; providing medical information relating to the treatment or prevention of cancer, tumors [ , ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ] ; medical consultation services relating to the treatment and diagnosis of cancer, tumors [ , ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ] ; medical counseling services relating to the treatment of cancer, tumors [ , ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ] ; [ genetic testing for medical purposes, namely, for the diagnosis and prognosis of the expected progression of cancer, tumors, ] [ ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; ] [ providing medical information relating to efficacy, side effects, and interactions of pharmaceuticals and medications; ] providing medical informationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Nov 4, 2026RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Nov 4, 202689AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Nov 2, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 20, 2026NA15SEC. 15 ACKNOWLEDGEMENT - E-MAILED—
Jan 20, 202615AKREGISTERED - SEC. 15 ACKNOWLEDGED—
Jan 20, 2026NA15SEC. 15 ACKNOWLEDGEMENT - E-MAILED—
Jan 20, 202615AKREGISTERED - SEC. 15 ACKNOWLEDGED—
Apr 14, 2025NA15SEC. 15 ACKNOWLEDGEMENT - E-MAILED—
Apr 14, 202515AKREGISTERED - SEC. 15 ACKNOWLEDGED—
Apr 7, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 5, 2025E89RTEAS SECTION 8 & 9 RECEIVED—
Mar 5, 2025E15RTEAS SECTION 15 RECEIVED—
Mar 31, 2024REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Apr 7, 2022NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Apr 7, 20228.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Mar 29, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 10, 2021ES8RTEAS SECTION 8 RECEIVED—
Apr 5, 2017CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Jan 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 31, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 13, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 24, 2014NPUBNOTICE OF PUBLICATION—
Dec 5, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 1, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 25, 2014CNEAEXAMINERS AMENDMENT MAILED—
Nov 24, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Nov 24, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 20, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 20, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 19, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 2, 2014CPRAPRIORITY ACTION MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 2, 2014CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 30, 2014DOCKASSIGNED TO EXAMINER—
Apr 25, 2014AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Apr 25, 2014ALIEASSIGNED TO LIE—
Apr 11, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 4, 2014PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 1, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance